ArticleJournal of oncology2022

CT-Based Radiomics Can Predict the Efficacy of Anlotinib in Advanced Non-Small-Cell Lung Cancer.

Jingyu Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.